Tobracid Dm 3 Gm

描述

Tobracid Dm 3 Gm Tablets (Tobramycin 0.3% & Dexamethasone 0.1% w/w Ophthalmic Ointment): Clinical Profile, Uses, Dosage, and Safety

Tobracid Dm 3 Gm Tablets is a prescription product containing Tobramycin 0.3% & Dexamethasone 0.1% w/w Ophthalmic Ointment. It is used in clinically selected treatment pathways and should be used only under professional supervision. This page summarizes core product facts to support informed discussions with licensed healthcare professionals.

Safe use depends on diagnosis, formulation, route, dose, and duration. For this reason, the sections below provide a structured profile aligned with clinical documentation standards for pharmaceutical education.

Introduction

Tobracid Dm 3 Gm Tablets is a ophthalmic solution manufactured by Entod Pharmaceuticals Ltd . Specifically designed for the management of steroid-r. It is commonly positioned within the antibiotic class and is typically prescribed for clearly defined therapeutic use cases. While product names are familiar to patients, treatment decisions should always be guided by clinical evaluation and official labeling.

Patients should verify product identity, strength, and route every time a medicine is dispensed. Similar-looking brand names can represent different active ingredients, and substitutions should only be made with clinician or pharmacist confirmation.

1. Product Overview / Clinical Profile

• Brand Name: Tobracid Dm 3 Gm Tablets
• Active Ingredient: Tobramycin 0.3% & Dexamethasone 0.1% w/w Ophthalmic Ointment
• Manufacturer: Entod Pharmaceuticals Ltd . Specifically designed for the management of steroid-r
• Dosage Form: ophthalmic solution
• Therapeutic Category: antibiotic

2. Mechanism of Action (MOA)

Tobracid Dm 3 Gm Tablets acts through Tobramycin 0.3% & Dexamethasone 0.1% w/w Ophthalmic Ointment, an antibacterial mechanism that inhibits critical microbial growth pathways and supports clearance of susceptible infections when used at the prescribed dose and duration.

Mechanistic understanding helps explain prescribing rationale, expected response timelines, and monitoring requirements. For antimicrobials, susceptibility patterns and resistance risk are central. For ocular pressure therapies, durable adherence and pressure control trends matter more than short-term symptom fluctuations. For anti-inflammatory and other chronic-use medicines, risk-benefit is reassessed through follow-up.

MOA should always be interpreted in context: pharmacology defines potential effect, but real-world response depends on diagnosis quality, adherence, interacting medicines, and patient-specific comorbid conditions.

3. Therapeutic Indications

Tobracid Dm 3 Gm Tablets is typically used for bacterial conjunctivitis and related susceptible ocular infections. Final indication should match local labeling, clinician judgement, and patient-specific risk profile.

• Use only for the indication selected by a licensed prescriber.
• Avoid self-initiating or extending treatment duration without clinical review.
• Reassessment is needed if expected improvement does not occur.

Clinical teams often adjust treatment based on severity, prior therapy exposure, and response monitoring. The objective is to achieve therapeutic benefit while minimizing avoidable adverse events.

4. Dosage and Administration

General dosing guidance: 3 mg (0, or as directed by the prescriber.

Exact schedules vary by diagnosis and patient profile. Prescribed instructions on label frequency, duration, and technique should be followed precisely.

• Use exactly as directed by the prescriber.
• Do not skip doses or double up missed doses unless advised.
• If ophthalmic, avoid touching the dropper/tube tip to any surface.
• If injectable, follow sterile handling and storage requirements.
• Ask the clinician for written missed-dose guidance at initiation.

药物给药质量可能显著影响治疗结果。正确的用药时间、给药途径和储存方式往往与选择正确的药物类别一样重要。

5. 安全性概况与注意事项

不良反应的发生率因活性成分和药物类别而异。患者应在首次使用前审阅禁忌症、过敏史、器官功能问题以及潜在的药物相互作用。若出现持续、严重或意外的症状，应及时就医评估。

重要的注意事项包括遵守既定疗程、避免自行增量用药、及时报告疗效不佳。对于眼科制剂，卫生和防污染控制至关重要；对于系统性药物，依据风险因素临床医生可能需要进行实验室监测。

立即就急诊护理，出现严重过敏反应、呼吸困难、进行性肿胀、突发视力改变或其他急性恶化等症状时。

储存与操作

按照官方产品标签进行储存。将药品保存在原包装中，远离热源和潮湿，并置于儿童不易触及的地方。眼科制剂应保持瓶盖封闭、避免污染；注射剂可能需要严格的温度控制。

处理过期或受损的产品。如包装出现破损，使用前应由药师或临床医生确认其适用性后再使用。

临床随访与患者教育要点

随访应评估临床反应、耐受性及用药依从性。鼓励患者保持药物清单、主动告知非处方药使用情况，并在不同医疗机构之间传递治疗变化。辅导时应强调本信息仅供参考，不能替代个体化诊断。

如适用，临床医生可依据当地抗菌药物管理、慢性病协议或专科路径来制定治疗方案，以保持疗效并降低可避免的风险。